Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
These effects help maintain glucose control and contribute to weight loss, making Ozempic a powerful tool in diabetes management
Each vial contains 10 mg of melanotan-2
| Atributo | Retatrutida | Tirzepatida | Semaglutida | |---|---|---|---| | Receptores | GLP-1 + GIP + GCG | GLP-1 + GIP | GLP-1 | | Vida media estimada | ~6 das | ~5 das | ~7 das | | Va estudiada | Subcutnea semanal | Subcutnea semanal | Subcutnea / oral | | Reduccin ponderal fase 2 | Hasta 24.2% | Hasta 22.5% | Hasta 15-17% | | Componente termognico | S (GCG-R) | No | No | Historia y desarrollo Retatrutida (cdigo LY3437943) fue desarrollada por Eli Lilly and Company como evolucin del programa incretnico que dio origen a dulaglutida (mono-GLP-1) y tirzepatida (dual GLP-1/GIP, comercializada como Zepbound)
Dietary Supplement Manufacturing USP Verified Mark
95% confidence interval [CI], 0.80 to 0.93), myocardial infarction by 13% (HR, 0.87
US$ 28.33
US$ 21.35
US$ 26.64
